Hormone Therapy

Adult-onset reversible idiopathic hypogonadotropic hypogonadism in male adult carrying a WDR11 missense mutation.

TL;DR

A man in his 20s developed adult-onset reversible idiopathic hypogonadotropic hypogonadism after fathering his first child, carrying a heterozygous missense variant in WDR11 (c.2390G>A; p.Arg797His), and achieved sustained improvement after 4 years of gonadotropin-releasing hormone replacement therapy that was then discontinued.

Key Findings

The patient developed adult-onset IHH after having his first child, presenting initially with gynecomastia.

  • The patient was a man in his 20s who had already fathered one child prior to diagnosis.
  • Initial presentation was gynecomastia, which led to the subsequent diagnosis of IHH.
  • This represents an unusual adult-onset presentation, as IHH occurs mostly in childhood or adolescence and very rarely in adulthood.
  • The case is notable because adult-onset IHH is characterized by delayed onset of secondary sexual characteristics in typical congenital cases, but this patient had prior normal reproductive function.

The patient carried a heterozygous missense variant in WDR11 (c.2390G>A; p.Arg797His) that may have contributed to adult-onset IHH and its reversal.

  • The variant identified was a heterozygous missense mutation: c.2390G>A; p.Arg797His in the WDR11 gene.
  • Many genetic abnormalities have been reported in congenital IHH cases, but genetic findings are rarely reported in adult-onset IHH cases.
  • The authors suggest this WDR11 variant 'may play a role in adult-onset IHH reversal.'
  • WDR11 mutations have been previously associated with IHH, and this case adds to understanding of the genetic component of the condition.

The patient's IHH was reversible; he responded to gonadotropin-releasing hormone replacement therapy, fathered two additional children, and sustained improvement after treatment discontinuation.

  • The patient was treated with gonadotropin-releasing hormone replacement therapy.
  • During treatment, he fathered two more children (for a total of three children).
  • Treatment was discontinued after 4 years.
  • Improvement was sustained after treatment discontinuation, consistent with the reversibility of IHH.
  • The authors note that 'IHH requires lifelong hormone replacement therapy; however, a few reports suggest the reversibility of this condition,' placing this case among rare reversible IHH cases.

Accumulation of adult-onset reversible IHH cases with identified genetic variants may contribute to understanding of IHH pathogenesis.

  • The authors state that 'accumulation of such cases can contribute to our understanding of the pathogenesis and genetic component of IHH.'
  • Genetic abnormalities have been rarely reported specifically in adult-onset IHH cases.
  • The identification of a WDR11 missense variant in this reversible adult-onset case highlights the potential genetic underpinnings of atypical IHH presentations.

Have a question about this study?

Citation

Yamada R, Yamakita N, Yasuda K, Imai A. (2022). Adult-onset reversible idiopathic hypogonadotropic hypogonadism in male adult carrying a WDR11 missense mutation.. BMJ case reports. https://doi.org/10.1136/bcr-2022-250444